Mobile

A clinical trial to compare the safety and effectiveness of Abraxane versus dacarbazine, in the treatment of advanced stage melanoma that has spread to other parts of the body (metastatic malignant me...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-004097-32

A clinical trial to compare the safety and effectiveness of Abraxane versus dacarbazine, in the treatment of advanced stage melanoma that has spread to other parts of the body (metastatic malignant melanoma)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to compare the following regimens with respect to antitumor activity in patients who are previously untreated with cytotoxic chemotherapy for metastatic malignant melanoma: • ABI-007 150 mg/m2 Days 1, 8, and 15 every 4 weeks • Dacarbazine 1000 mg/m2 every 3 weeks

Critère d'inclusion

  • Metastatic Malignant Melanoma

Liens